electroCore (ECOR) Expected to Release Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECOR) is expected to be announcing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to announce earnings of ($0.26) per share and revenue of $10.93 million for the quarter. Interested persons may visit the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 4:30 PM ET.

electroCore (NASDAQ:ECOR) last announced its earnings results on Thursday, August 6th. The company reported ($0.33) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.09. The business had revenue of $9.45 million for the quarter, compared to the consensus estimate of $9.49 million. On average, analysts expect electroCore to post ($1.40) EPS for the current fiscal year and ($0.68) EPS for the next fiscal year.

electroCore Price Performance

Shares of ECOR opened at $7.76 on Wednesday. electroCore has a twelve month low of $4.41 and a twelve month high of $12.70. The firm has a 50 day moving average of $9.64 and a 200 day moving average of $7.70.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a report on Monday, September 21st. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $18.00.

Insiders Place Their Bets

In related news, CFO Joshua S. Lev sold 12,000 shares of electroCore stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $10.22, for a total value of $122,640.00. Following the completion of the transaction, the chief financial officer owned 84,889 shares in the company, valued at approximately $867,565.58. The trade was a 12.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas Errico purchased 5,000 shares of the business’s stock in a transaction on Thursday, August 13th. The shares were bought at an average price of $9.85 per share, for a total transaction of $49,250.00. Following the acquisition, the director owned 343,332 shares in the company, valued at $3,381,820.20. This trade represents a 1.48% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders sold a total of 20,000 shares of company stock worth $200,120 in the last 90 days. 7.80% of the stock is currently owned by insiders.

electroCore Company Profile

electroCore, Inc (NASDAQ: ECOR) is a commercial-stage medical device company focused on bioelectronic medicine and non-invasive vagus nerve stimulation (nVNS). Its technology is designed to stimulate the vagus nerve through the neck without requiring surgery or implanted components.

The company’s primary prescription product is gammaCore, a handheld nVNS device used for the acute treatment of pain associated with migraine and episodic cluster headaches in adults. electroCore also markets consumer-oriented products, including Truvaga, a handheld vagus nerve stimulation device positioned for general wellness applications.